Clinical Trial Update: Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial is evaluating long-term maintenance with ketamine and esketamine to reduce suicide risk in adults with Major Depressive Disorder; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Esketamine (esketamine)
• Ketamine (ketamine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder | Phase 4 | Status: RECRUITING